4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-046870
Options or other derivatives
- SVP, Diagnostics, clonoSEQ acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-046870
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…